28th Feb 2025 15:44
28 February 2025
The following amendment has been made to the 'Result of General Meeting' announcement released on 28 February 2025 at 13:32 under RNS No 9338Y:
The earlier announcement included a misspelling of Dr Pat Strollo's surname under the section titled 'Board Changes'. This has now been corrected.
All other details remain unchanged.
The full amended text is shown below.
-------------------------------------------------------------------
Belluscura plc
("Belluscura" or the "Company")
Result of General Meeting
Directors' shareholdings
Board Changes
Belluscura plc (AIM: BELL), a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies, is pleased to announce that at the General Meeting held earlier today both the Resolutions were approved by Shareholders:
Resolution(*indicates special resolution) | Votes for† | % of shares voted | Votes against | % of shares voted |
Resolution 1: To allot, inter alia, the Conditional Placing Shares, the VCT/EIS Placing Shares and the WRAP Retail Offer Shares | 93,467,247 | 99.92 | 73,996 | 0.08 |
Resolution 2*: To disapply StatutoryPre-Emption Rights | 93,467,247 | 99.92 | 73,996 | 0.08 |
† Proxy appointments which gave discretion to the Chairman have been included in the "for" total.
The Company is pleased to confirm that as a result of the issue of the Conditional Placing Shares, the VCT/EIS Placing Shares and the WRAP Retail Offer Shares, which are subject to Admission, together with the Firm Placing which completed on 11 February 2025, the Company has raised total gross proceeds of approximately £4.7 million.
Admission and Total Voting Rights
Application has been made to the London Stock Exchange for admission of the 109,616,986 Conditional Placing Shares, the 56,534,389 VCT/EIS Placing Shares and the 33,750,000 WRAP Retail Offer Shares to trading on AIM.
It is expected that Admission will become effective and dealings in the VCT/EIS Placing Shares and the WRAP Retail Offer Shares will commence on AIM at 8.00 a.m. on or around 4 March 2025.
It is expected that Admission will become effective and dealings in the Conditional Placing Shares and will commence on AIM at 8.00 a.m. on or around 5 March 2025 ("Third Admission").
The Conditional Placing Shares, the VCT/EIS Placing Shares and the WRAP Retail Offer Shares will be issued fully paid and will rank pari passu in all respects with the Company's existing Ordinary Shares.
Following the Third Admission on 5 March 2025, the total number of Ordinary Shares in the capital of the Company in issue will be 401,309,607 with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's issued share capital pursuant to the Company's Articles.
Directors' Shareholdings following Admission
On Third Admission, the revised shareholdings of the following current Directors will be:
Name | Holding ofOrdinary Shares | % of Enlargedissued share capital |
Adam Reynolds | 4,545,233 | 1.13% |
Robert Rauker | 3,045,330 | 0.76% |
David Poutney** | 15,260,554 | 3.80% |
Ric Piper | 1,808,295 | 0.45% |
Dr Pat Strollo | 964,630 | 0.24% |
Paul Tuson | 602,893 | 0.15% |
Bob Fary | 32,000 | 0.01% |
** Including shares held by Vivienne Poutney, Mr Poutney's spouse.
Board Changes
The proposed board changes announced on 6 February 2025 will become effective upon Third Admission when Adam Reynolds, David Poutney, Dr Pat Strollo and Bob Fary will each resign from the Board.
Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the Announcement made by the Company at 5.22 p.m. on 6 February 2025.
Enquiries:
For further information please contact:
Belluscura plc | Tel: +44 (0)20 3128 8100 |
Adam Reynolds, Chairman Robert Rauker, Chief Executive Officer Simon Neicheril, Chief Financial Officer
|
|
SPARK Advisory Partners Limited Nominated Adviser | Tel: +44 (0)20 3368 3550 |
Neil Baldwin / Jade Bayat
|
|
Dowgate Capital Limited Joint Broker | Tel: +44 (0)20 3903 7715 |
James Serjeant / Colin Clime (Sales and Corporate Broking) Russell Cook / Daniel Ingram (Corporate Finance) |
|
|
|
Allenby Capital Ltd Joint Broker | Tel: +44 (0)20 3328 5656
|
Guy McDougall / Amrit Nahal (Sales and Corporate Broking) Jeremy Porter / Lauren Wright (Corporate Finance)
|
|
MHP Financial PR & Investor Relations | Tel: +44 (0)20 3128 8100 email: [email protected] |
Katie Hunt/Matthew Taylor |
|
For further information, please visit https://ir.belluscura.com/
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Adam Reynolds | ||||
2 | Reason for notification | |||||
a) | Position / status | Non Executive Chairman | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Belluscura plc | ||||
b) | LEI | 213800BRJQZE56XBPW94 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11 | ||||
b) | Nature of the transaction | Acquisition of ordinary shares of £0.01 each in a subscription;
| ||||
c) | Price(s) and volumes(s)
|
| ||||
d) | Aggregated information | n/a | ||||
e) | Date of the transaction | 28 February 2025 | ||||
f) | Place of the transaction | Outside a Trading Venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Robert Rauker | ||||
2 | Reason for notification | |||||
a) | Position / status | Chief Executive Officer | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Belluscura plc | ||||
b) | LEI | 213800BRJQZE56XBPW94 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11 | ||||
b) | Nature of the transaction | Acquisition of ordinary shares of £0.01 each in a subscription;
| ||||
c) | Price(s) and volumes(s)
|
| ||||
d) | Aggregated information | n/a | ||||
e) | Date of the transaction | 28 February 2025 | ||||
f) | Place of the transaction | Outside a Trading Venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | David Poutney | ||||
2 | Reason for notification | |||||
a) | Position / status | Non Executive Director | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Belluscura plc | ||||
b) | LEI | 213800BRJQZE56XBPW94 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11 | ||||
b) | Nature of the transaction | Acquisition of ordinary shares of £0.01 each in a subscription;
| ||||
c) | Price(s) and volumes(s)
|
| ||||
d) | Aggregated information | n/a | ||||
e) | Date of the transaction | 28 February 2025 | ||||
f) | Place of the transaction | Outside a Trading Venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Paul Tuson | ||||
2 | Reason for notification | |||||
a) | Position / status | Non Executive Director | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Belluscura plc | ||||
b) | LEI | 213800BRJQZE56XBPW94 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11 | ||||
b) | Nature of the transaction | Acquisition of ordinary shares of £0.01 each in a subscription;
| ||||
c) | Price(s) and volumes(s)
|
| ||||
d) | Aggregated information | n/a | ||||
e) | Date of the transaction | 28 February 2025 | ||||
f) | Place of the transaction | Outside a Trading Venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Dr Patrick Strollo | ||||
2 | Reason for notification | |||||
a) | Position / status | Non Executive Director | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Belluscura plc | ||||
b) | LEI | 213800BRJQZE56XBPW94 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11 | ||||
b) | Nature of the transaction | Acquisition of ordinary shares of £0.01 each in a subscription;
| ||||
c) | Price(s) and volumes(s)
|
| ||||
d) | Aggregated information | n/a | ||||
e) | Date of the transaction | 28 February 2025 | ||||
f) | Place of the transaction | Outside a Trading Venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Richard Piper | ||||
2 | Reason for notification | |||||
a) | Position / status | Non Executive Director | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Belluscura plc | ||||
b) | LEI | 213800BRJQZE56XBPW94 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.01 each in Belluscura plc ISIN: GB00BD3B8Z11 | ||||
b) | Nature of the transaction | Acquisition of ordinary shares of £0.01 each in a subscription;
| ||||
c) | Price(s) and volumes(s)
|
| ||||
d) | Aggregated information | n/a | ||||
e) | Date of the transaction | 28 February 2025 | ||||
f) | Place of the transaction | Outside a Trading Venue | ||||
Related Shares:
Belluscura